Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,420,125
+$401,940 QoQ
Shares Held
1,184
+7.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#2,824
of 4,605 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hexagon Capital Partners LLC holds $11,707,728 across 11 Drug Manufacturers - General names. LLY ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,314 | $2,092,134 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,420 | $1,724,470 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,184 | $1,420,125 | |
| 4 | PFE |
Pfizer Inc
|
54,852 | $1,320,836 | |
| 5 | JNJ |
Johnson & Johnson
|
5,167 | $1,312,262 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
18,323 | $1,055,771 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,901 | $871,872 | |
| 8 | NVS |
Novartis AG
|
3,990 | $625,312 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,420,125 | 1,184 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,018,185 | 1,107 | Shares | Sole | 2026-05-05 | |
| 2025-03-31 | $679,723 | 823 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $662,376 | 858 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $622,815 | 703 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $673,602 | 744 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $560,131 | 720 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $372,485 | 639 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $315,832 | 588 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $297,802 | 635 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $219,788 | 640 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $231,576 | 633 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $195,626 | 605 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $176,705 | 545 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $212,772 | 743 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $218,213 | 790 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $204,017 | 883 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $183,616 | 800 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $168,138 | 900 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $246,506 | 1,460 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $226,470 | 1,530 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||